Table of Contents

company-logo

Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, CMO and Contract Development Organization (CDO). It is involved in the provision of CDO services, including cell line development, upstream and downstream processes, and analytical methods and formulations. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the development and commercialization of biosimilar drugs; and manufactures mammalian cell-based antibody drugs. The company was founded in 2011 and is headquartered in Incheon, South Korea.

Samsung Biologics Dividend Announcement

• Samsung Biologics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Samsung Biologics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Samsung Biologics Dividend History

Samsung Biologics Dividend Yield

Samsung Biologics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Samsung Biologics stock? Use our calculator to estimate your expected dividend yield:

Samsung Biologics Financial Ratios

P/E ratio66.68
PEG ratio18.52
P/B ratio6.79
ROE10.60%
Payout ratio0.00%
Current ratio1.35
Quick ratio0.66
Cash Ratio0.24

Samsung Biologics Dividend FAQ

Does Samsung Biologics stock pay dividends?
Samsung Biologics does not currently pay dividends to its shareholders.
Has Samsung Biologics ever paid a dividend?
No, Samsung Biologics has no a history of paying dividends to its shareholders. Samsung Biologics is not known for its dividend payments.
Why doesn't Samsung Biologics pay dividends?
There are several potential reasons why Samsung Biologics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Samsung Biologics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Samsung Biologics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Samsung Biologics a dividend aristocrat?
Samsung Biologics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Samsung Biologics a dividend king?
Samsung Biologics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Samsung Biologics a dividend stock?
No, Samsung Biologics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Samsung Biologics stocks?
To buy Samsung Biologics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Samsung Biologics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.